dasatinib zentiva 50 mg filmtabletten
helvepharm ag - dasatinibum - filmtabletten - dasatinibum 50 mg, lactosum monohydricum 67.5 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.36 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 1.68 mg, e 171, triacetinum, pro compresso obducto. - philadelphiachromosom-positive chronische myeloische leukämie; philadelphiachromosom-positive akute lymphatische leukämie - synthetika
dasatinib zentiva 70 mg filmtabletten
helvepharm ag - dasatinibum - filmtabletten - dasatinibum 70 mg, lactosum monohydricum 94.5 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.5 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 2.35 mg, e 171, triacetinum, pro compresso obducto. - philadelphiachromosom-positive chronische myeloische leukämie; philadelphiachromosom-positive akute lymphatische leukämie - synthetika
dasatinib zentiva 80 mg filmtabletten
helvepharm ag - dasatinibum - filmtabletten - dasatinibum 80 mg, lactosum monohydricum 108 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.58 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 2.69 mg, e 171, triacetinum, pro compresso obducto. - philadelphiachromosom-positive chronische myeloische leukämie; philadelphiachromosom-positive akute lymphatische leukämie - synthetika
dasatinib zentiva 100 mg filmtabletten
helvepharm ag - dasatinibum - filmtabletten - dasatinibum 100 mg, lactosum monohydricum 135 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.72 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 3.36 mg, e 171, triacetinum, pro compresso obducto. - philadelphiachromosom-positive chronische myeloische leukämie; philadelphiachromosom-positive akute lymphatische leukämie - synthetika
dasatinib zentiva 140 mg filmtabletten
helvepharm ag - dasatinibum - filmtabletten - dasatinibum 140 mg, lactosum monohydricum 189 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.72 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 4.7 mg, e 171, triacetinum, pro compresso obducto. - philadelphiachromosom-positive chronische myeloische leukämie; philadelphiachromosom-positive akute lymphatische leukämie - synthetika
dasatinib accord
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastische mittel - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastische mittel - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
dasatinib spirig hc 20 mg filmtabletten
spirig healthcare ag - dasatinibum - filmtabletten - filmtablette: dasatinibum 20.00 mg, lactosum monohydricum 27.00 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.14 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 0.67 mg, e 171, triacetinum, pro compresso obducto. - onkologikum - synthetika
dasatinib spirig hc 50 mg filmtabletten
spirig healthcare ag - dasatinibum - filmtabletten - filmtablette: dasatinibum 50.00 mg, lactosum monohydricum 67.50 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.36 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 1.68 mg, e 171, triacetinum, pro compresso obducto. - onkologikum - synthetika
dasatinib spirig hc 70 mg filmtabletten
spirig healthcare ag - dasatinibum - filmtabletten - filmtablette: dasatinibum 70.00 mg, lactosum monohydricum 94.50 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.5 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 2.35 mg, e 171, triacetinum, pro compresso obducto. - onkologikum - synthetika